Table 4.
Comparative study in terms of severity scale (CALL score)
| Class A and B (low and intermediate risk) n=29 |
Class C (high risk) n=37 |
p | |
|---|---|---|---|
| Age, median, IQR | 51 (34.5-71) | 76 (64-86) | <0.01 |
| Charlson Index, median, IQR | 0 (0-5) | 4 (2-6.5) | <0.01 |
| Oxygen saturation on admission, median, IQR | 95 (94-97) | 92 (88-95) | <0.01 |
| Dyspnoea, n, % | 4/29 (13.8%) | 15/37 (40.5%) | 0.027 |
| Antibiotic treatment, n, % | 19/29 (65.5%) | 33/37 (89.2%) | 0.032 |
| Complications | |||
| Cardiopathy, n, % | 2/29 (6.9%) | 3/37 (35.1%) | <0.01 |
| ARDS, n, % | 6/29 (20.7%) | 18/37 (48.6%) | 0.023 |
| Kidney injury, n, % | 5/29 (17.2%) | 28/37 (48.6%) | 0.01 |
| Survivor at 30-day follow-up (at home), n, % | 26/29 (89.7%) | 18/37 (48.6%) | <0.01 |
| Laboratory | |||
| Lymphocyte count, median, IQR | 1.3 (1.1-1.5) | 0.7 (0.4-0.9) | <0.01 |
| C-reactive protein, median, IQR | 2.3 (1.3-4.7) | 5.3 (2.8-11.8) | <0.01 |
| Procalcitonin, median, IQR | 0.04 (0.03-0.06) | 0.09 (0.04-0.3) | <0.01 |
| LDH, median, IQR | 212 (190.5-267.5) | 283 (211.5-399.5) | <0.01 |
ARDS: acute respiratory distress syndrome